Compare MGTX & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | GES |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 665.7M | 872.4M |
| IPO Year | N/A | 1996 |
| Metric | MGTX | GES |
|---|---|---|
| Price | $8.20 | $16.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $23.83 | $19.88 |
| AVG Volume (30 Days) | ★ 620.5K | 461.6K |
| Earning Date | 11-13-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 5.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | $27,417,000.00 | ★ $3,144,417,000.00 |
| Revenue This Year | N/A | $8.97 |
| Revenue Next Year | $619.95 | $4.07 |
| P/E Ratio | ★ N/A | $15.65 |
| Revenue Growth | ★ 96.83 | 6.44 |
| 52 Week Low | $4.55 | $8.48 |
| 52 Week High | $9.73 | $17.15 |
| Indicator | MGTX | GES |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 42.59 |
| Support Level | $7.84 | $16.73 |
| Resistance Level | $8.53 | $16.85 |
| Average True Range (ATR) | 0.55 | 0.07 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 35.84 | 12.12 |
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.